TrialJournal of translational medicine2019

First-in-human study of TK-positive oncolytic vaccinia virus delivered by adipose stromal vascular fraction cells.

Boris R Minev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.